10 employees
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
2010
$350K
from 3 investors over 3 rounds
Longevity Biotech raised $316K on November 9, 2017
Investors: National MS Society
Longevity Biotech raised $350K on April 26, 2012
Investors: Breakout Labs and The Thiel Foundation